Cytomegalic Inclusion Disease
Symptoms, Doctors, Treatments, Advances & More

Save information for later
Sign Up

Learn About Cytomegalic Inclusion Disease

What is the definition of Cytomegalic Inclusion Disease?
Cytomegalic inclusion disease is an infection in newborns caused by the cytomegalovirus. When a pregnant woman has an active cytomegalovirus infection during pregnancy or breastfeeding, the virus can be passed to their babies. Cytomegaloviruses are also known as salivary gland viruses.
What are the symptoms of Cytomegalic Inclusion Disease?
Symptoms of cytomegalic inclusion disease in the newborn can range from no symptoms to severe symptoms affecting the central nervous system, liver, spleen, and possibly causing developmental disabilities. Other symptoms of severe cytomegalic inclusion disease in infants may include hemorrhagic anemia, low birth weight, fever, hepatitis, yellowing of the skin and whites of the eyes, rash, purple skin blotches, pneumonia, enlarged liver and/or spleen, decreased blood platelets, eye inflammation, abnormally small head, calcification of the ventricles of the brain, developmental motor defects, cognitive disabilities, spastic paralysis, blindness, deafness, and seizures.
Not sure about your diagnosis?
Check Your Symptoms
What are the current treatments for Cytomegalic Inclusion Disease?
There is currently no cure for cytomegalic inclusion disease. Treatment for cytomegalic inclusion disease is focused on controlling symptoms. Treatments for cytomegalic inclusion disease include antiviral drugs, such as gancicolovir and foscarnet; azathioprine; prednisone; basiliximab; and miconazole.
Who are the top Cytomegalic Inclusion Disease Local Doctors?
Elite in Cytomegalic Inclusion Disease
Infectious Disease
Elite in Cytomegalic Inclusion Disease
Infectious Disease
Referral may be required

Johns Hopkins Health Care & Surgery Center - Green Spring Station, Lutherville

10751 Falls Road, Falls Concourse STE 412, Falls Concourse STE 412, 
Lutherville, MD 
Languages Spoken:
English
Accepting New Patients
Offers Telehealth

Robin Avery is an Infectious Disease provider practicing medicine in Lutherville, Maryland. Dr. Avery is rated as an Elite provider by MediFind in the treatment of Cytomegalic Inclusion Disease. She is also highly rated in 9 other conditions, according to our data. Her clinical expertise encompasses Cytomegalic Inclusion Disease, Cytomegalovirus Infection, COVID-19, and Severe Acute Respiratory Syndrome (SARS). Dr. Avery is board certified in American Board Of Internal Medicine. Dr. Avery is currently accepting new patients.

Elite in Cytomegalic Inclusion Disease
Infectious Disease
Elite in Cytomegalic Inclusion Disease
Infectious Disease
Referral may be required

Rachel Loschiavo PA-C

825 Eastlake Ave E, 
Seattle, WA 
Languages Spoken:
English, Castilian, German, Punjabi, Russian, Spanish, Urdu
Accepting New Patients
Offers Telehealth

Michael Boeckh is an Infectious Disease provider practicing medicine in Seattle, Washington. Dr. Boeckh is rated as an Elite provider by MediFind in the treatment of Cytomegalic Inclusion Disease. He is also highly rated in 10 other conditions, according to our data. His clinical expertise encompasses Cytomegalovirus Infection, Cytomegalic Inclusion Disease, Parainfluenza, and Shingles. Dr. Boeckh is currently accepting new patients.

 
 
 
 
Learn about our expert tiers
Learn More
Elite in Cytomegalic Inclusion Disease
Elite in Cytomegalic Inclusion Disease
Referral may be required

St Orsola Malpighi University Hospital

Bologna, IT 

Tiziana Lazzarotto practices practicing medicine in Bologna, Italy. Ms. Lazzarotto is rated as an Elite expert by MediFind in the treatment of Cytomegalic Inclusion Disease. She is also highly rated in 12 other conditions, according to our data. Her clinical expertise encompasses Congenital Cytomegalovirus, Cytomegalovirus Infection, Cytomegalic Inclusion Disease, Hepato-Pancreato-Biliary Surgery, and Bone Marrow Transplant.

What are the latest Cytomegalic Inclusion Disease Clinical Trials?
Phase 2, Randomized, Open-label, Active Comparator, Dose-ranging Study Evaluating the Efficacy and Safety of Artesunate for Injection in Combination With Ganciclovir or Valganciclovir for the Treatment of Cytomegalovirus Infection in Solid Organ Transplant Recipients

Summary: This study is a randomized, open-label, active comparator-controlled, dose-ranging trial of the efficacy and safety of IV artesunate in combination with IV GCV or oral VGCV and SOC treatment compared to GCV or VGCV monotherapy and SOC treatment in SOT recipients with clinically significant CMV infection.

Match to trials
Find the right clinical trials for you in under a minute
Get started
Single Center Phase I Study of Adoptive Immunotherapy of Refractory Viral Infection With ex Vivo Expanded Rapidly Generated Virus Specific T (R-MVST) Cells for Immunodeficient Children and Young Adults

Summary: The primary objective is to determine the safety and feasibility of administering R-MVST cells to patients with refractory viral reactivation and/or symptomatic disease caused by Epstein Barr Virus (EBV), cytomegalovirus (CMV), adenovirus (ADV) or BK virus. R-MVST cells will be generated on-demand from the closest partially human leukocyte antigen (HLA)-matched (minimum haploidentical) healthy don...